"Centro de referencia internacional en oftalmología con más de 25 año buscando solución a cualquier problema ocular mediante la aplicación experta de los mejores tratamientos. El Instituto de Microcirugía Ocular (IMO) cuenta con un equipo médico altamente especializado y comprometido, con la tecnología más avanzada, y con unas instalaciones amplias, cómodas y modernas. Nos mueve la excelencia médica y la calidad humana, que se concreta en un equipo volcado en la atención al paciente."

During the past decade, Instituto de Microcirugia Ocular conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Microcirugia Ocular" #1 sponsor was "Association for Innovation and Biomedical Research on Light and Image" with 2 trials, followed by "Gyroscope Therapeutics Limited" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Biotechnology Institute IMASD" with 1 trials sponsored and "Fundacion Clinic per a la Recerca Biomédica" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Microcirugia Ocular" #1 collaborator was "European Vision Institute Clinical Research Network" with 2 trials as a collaborator, "Novartis Pharmaceuticals" with 2 trials as a collaborator and "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Microcirugia Ocular" are "Geographic Atrophy" (3 trials), "Dry Age-related Macular Degeneration" (2 trials), "Macular Degeneration" (2 trials), "Choroideremia" (1 trials) and "Cone Rod Dystrophy" (1 trials). Many other conditions were trialed in "Instituto de Microcirugia Ocular" in a lesser frequency.

Most popular intervention types in "Instituto de Microcirugia Ocular" are "Drug" (8 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (2 trials), "Artificial tears eye-drops" (1 trials), "CyPass Micro-Stent" (1 trials), "GT005: High Dose" (1 trials) and "GT005: Medium Dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Microcirugia Ocular" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Microcirugia Ocular". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Instituto de Microcirugia Ocular, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Microcirugia Ocular, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".